Fennec Pharmaceuticals Inc.
TSX : FRX
OTCQB : FENCF

Fennec Pharmaceuticals Inc.

June 08, 2016 17:00 ET

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - June 8, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today announced that the nominees listed in the management proxy circular dated May 9, 2016 (the "Circular") for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Boston, Massachusetts on June 8, 2016 (the "Meeting"). Detailed results of the vote for the election of directors are set out below:


Name of Nominee

Votes For

% Votes For

Votes Withheld

% Votes Withheld
Dr. Khalid Islam 5,960,408 99.95% 2,856 0.05%
Mr. Adrian Haigh 5,960,335 99.95% 2,929 0.05%
Mr. Chris A. Rallis 5,960,335 99.95% 2,929 0.05%
Mr. Rostislav Raykov 5,960,335 99.95% 2,929 0.05%

Contact Information

  • Fennec Pharmaceuticals Inc.
    Rosty Raykov
    Chief Executive Officer
    (919) 636-5144